Effects of perfluorooctylbromide and vitamin E on ischemia induced retinal oxidative tissue damage

Protective effects of various antioxidants during ischemia-reperfusion in the rat retina

BACKGROUND

Oxidative stress during ischemia-reperfusion (I/R) is thought to be a major cause of retinal injury after I/R. The present study was aimed at investigating the protective role of antioxidant application.

METHODS

Four commonly used antioxidants (vitamin E=alpha tocopherol, lutein, fenugreek=Trigonella foenum-graecum and germander=Teucrium multicaule) were applied in ischemia-reperfusion (I/R) injury of the right retinae of 51 adult pigmented rats. Each of the antioxidants was administered every 6 h, beginning 6 h before the ischemia. After 60 min ischemia and 24 h reperfusion, we assayed (1) oxidative damage by measuring malondialdehyde (MDA), (2) apoptosis by measuring activated caspase-3 (using immunoblots), and (3) intrinsic antioxidative capacity by measuring glutathione (GSH) levels in the retinae.

RESULTS

In the order of lutein>Trigonella>vitamin E>Teucrium, all four compounds were effective in preventing retinal damage by I/R, as (1) they significantly decreased the formation of MDA (8.83, 16.48, 17.24, 18.5 nmol/100 mg tissue wet weight, respectively) compared with I/R without protection (23.29 nmol/100 mg tissue wet weight; controls: 8.0 nmol/100 mg tissue wet weight); (2) they significantly inhibited the activation of caspase-3 [0.01, 0.02, 0,02, and 0.04 arbitrary units (AU), respectively, versus control, 0.0, and I/R, 0.08 AU]; and (3) they significantly decelerated the loss of GSH (from control levels of 36.04 nmol/100 mg tissue wet weight) to 30.4, 15.98, 18.1, 15.02 nmol/100 mg tissue wet weight, respectively (lutein, Trigonella, vitamin E, Teucrium), compared with unprotected I/R (12.84 nmol/100 mg tissue wet weight).

CONCLUSIONS

Our study shows that lutein, Trigonella, Teucrium and vitamin E exert protection against in vivo retinal I/R injury in rats; this may recommend these compounds (in particular, lutein) for clinical use in patients with different types of ocular I/R injuries.

Neuroprotective effects of minocycline against in vitro and in vivo retinal ganglion cell damage

The purpose of this study was to determine whether minocycline, a semi-synthetic tetracycline derivative, reduces (a) the in vitro neuronal damage occurring after serum deprivation in cultured retinal ganglion cells (RGC-5, a rat ganglion cell line transformed using E1A virus) and/or (b) the in vivo retinal damage induced by N-methyl-D-aspartate (NMDA) intravitreal injection in mice. In addition, we examined minocycline's putative mechanisms of action against oxidative stress and endoplasmic reticulum (ER) stress. In vitro, retinal damage was induced by 24-h serum deprivation, and cell viability was measured by Hoechst 33342 staining or resazurin reduction assay. In cultures of RGC-5 cells maintained in serum-free medium for up to 24 h, the number of cells undergoing cell death was reduced by minocycline (0.2-20 microM). Serum deprivation resulted in increased oxidative stress, as revealed by an increase in the fluorescence intensity for 5-(and-6)-chloromethyl-2', 7'-dichlorodihydrofluorescein diacetate (CM-H2DCFDA), a reactive oxygen species (ROS) indicator. Minocycline at 2 and 20 microM inhibited this ROS production. However, even at 20 microM minocycline did not inhibit the retinal damage induced by tunicamycin (an ER stress inducer). Furthermore, in mice in vivo minocycline at 90 mg/kg intraperitoneally administered 60 min before an NMDA intravitreal injection reduced the NMDA-induced retinal damage. These findings indicate that minocycline has neuroprotective effects against in vitro and in vivo retinal damage, and that an inhibitory effect on ROS production may contribute to the underlying mechanisms.

Antioxidant effects of alpha-, gamma- and succinate-tocopherols in guinea pig retina during ischemia-reperfusion injury

The purpose of this study is to investigate the efficacy of alpha-tocopherol (AT), gamma-tocopherol (GT) and d-alpha-tocopherol polyethylene glycol 1000 succinate (TPGS) in preventing the retinal injury followed by ischemia-reperfusion (IR). The eyes of 40 adult male guinea pigs were used in the study. The guinea pigs were divided into five groups of eight rats each. First and second groups were used as control and IR groups, respectively. Third, fourth and fifth groups received subcutaneously AT, GT and TPGS, respectively. Treatment with each vitamin was performed before 5min of ischemia with reperfusion at 6h intervals for three times. Retinal ischemia was induced for 90min, then followed by reperfusion for 24h. The animals were killed at 24h of reperfusion. Lipid peroxidation (LP) and glutathione (GSH) levels were measured in right retinas by using a spectrofluorometer. Retinal GSH levels were found significantly lower (p < 0.002) in the IR group than in control group and there was a significant increase in the LP levels in IR group (p < 0.001). The decrease of GSH and increase of LP levels in the IR animals were significantly (p < 0.05 and 0.001) improved by the administration of the Vitamin E forms. When compared to GT group, there were no significant differences in LP levels in AT and TPGS groups. However, LP level in AT group was significantly (p < 0.01) lower than in the TPGS group. The GSH levels were higher (p < 0.001) in AT and TPGS groups than in IR group. Therefore, modulator effect of AT and GT were greater than that of TPGS. In conclusion, present data demonstrate that there is an increase in the LP in the retina of IR-induced animals and a decrease in the GSH levels. However, subcutaneous AT, GT and TPGS were effective in preventing retinal injury followed by ischemia-reperfusion. The subcutaneous AT may play a role in treating IR injury.

Administration of high dose intravitreal melatonin degenerates retinal cells in guinea pigs

The purpose of this study was to investigate the influence of intravitreally injected different doses of melatonin on retinal morphology. The right eyes of 35 male albino guinea pigs were used. The animals were classified randomly into five groups in equal numbers. First group was used as control and received intravitreal injection of placebo. Groups 2, 3, 4 and 5 received intravitreally injections of melatonin at 50, 100, 150 and 200microg/body weight (BW) each, respectively. The animals were sacrificed 15 days after the injections. The eyes were enucleated and processed for light microscopic evaluation. Intravitreal injection of melatonin at doses ranging from 50 to 150microg did not induce morphological changes, although a higher thickness of the inner plexiform layer (IPL) was found in Group 5 compared to other groups (p < 0.05). The mean retinal ganglion cell (RGC) counts were found to be lower in Group 5 compared to other groups (p < 0.05). Our findings indicate that intravitreal injection of melatonin at doses ranging from 50 to 150microg/BW does not induce morphological changes. The dose of 200microg/BW produced significant damage including retinal ganglion cell loss and formation of retinal edema.

Protection of the retina from ischemia-reperfusion injury by L-carnitine in guinea pigs

PURPOSE

To investigate the efficacy of L-carnitine in preventing retinal injury followed by ischemia-reperfusion.

METHODS

The eyes of 34 guinea pigs were used in this experiment. The guinea pigs were divided into two groups: the first group (n=17) was given L-carnitine intraperitoneally (500 mg/kg) and second group (n=17) received the same dose of saline solution. Under general anesthesia, peritomy was performed. Retro-orbital tissues were ligated for 90 minutes and ischemia was induced, followed by 4 hours of reperfusion. One of the enucleated eye was stained with hematoxylin and eosin (H&E) and retinal thicknesses were evaluated. Thiobarbituric acid reactive substances (TBARS) levels were determined in the retina of the other eye.

RESULTS

Mean TBARS levels in retinal tissue were found lower in L-carnitine group (2.77 +/- 0.55 microM) than in the control group (6.57 +/- 1.19 microM), (p<0.01). On the other hand, mean retinal thickness was found to be increased in the control group (47.47 +/- 5.62 microm) when compared to the L-carnitine group (26.52 +/- 4.65 microm), (p<0.01). In correlation analysis, significantly positive relationships were found between retinal TBARS level and retinal thickness both in the control and L-carnitine groups (r=0.981, p<0.01 and r= 0.967, p<0.01 respectively).

CONCLUSIONS

L-carnitine is effective in preventing retinal injury followed by ischemia-reperfusion.